Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
What are the side effects of gilitinib?The FLT3 inhibitor Gilteritinib (Xospata)···【more】
Release date：2024-11-21Recommended：142
Gireltinib is primarily effective in acute myeloid leukemia (AML), particularly ···【more】
Release date：2024-11-21Recommended：144
Patients with non-small cell lung cancer (NSCLC) with anaplastic lymphoma kinase···【more】
Release date：2024-11-20Recommended：191
Lorlatinib is a highly potent third-generation ALK and ROS1 tyrosine kinase inhi···【more】
Release date：2024-11-20Recommended：218
The tropomyosin receptor kinase (TRK) fusion protein produced by the fusion of t···【more】
Release date：2024-11-19Recommended：172
How to buy generic larotrectinib?Vitrakvi, a highly selective oral tropomyosin r···【more】
Release date：2024-11-19Recommended：121
1. Product IngredientsEntrectinib is a small molecule tyrosine kinase inhibitor ···【more】
Release date：2024-11-18Recommended：175
1. Product IngredientsThe chemical name of afatinib is N-{4-(3-chloro-4-fluoroph···【more】
Release date：2024-11-18Recommended：148
In a phase 1 study, sotorasib showed anticancer activity in patients with advanc···【more】
Release date：2024-11-15Recommended：150
According to NCCN guidelines, for patients with KRASG12C-mutated non-small cell ···【more】
Release date：2024-11-15Recommended：240
Cabobrutinib is a tyrosine kinase inhibitor that primarily targets MET, VEGFR an···【more】
Release date：2024-11-14Recommended：227
Pralsetinib is a selective RET kinase inhibitor indicated for the treatment of R···【more】
Release date：2024-11-14Recommended：210
